David P Meeker Receives Stock Award at Trevi Therapeutics Inc (TRVI) — SEC Form 4, Jul 01, 2022

This is an amended filing (Form 4/A) — it supersedes the original filed June 23, 2022.

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

David P Meeker

Director

TXN 2022-06-23 · FILED 2022-07-01

Filing Lag 6 business days late vs 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Trevi Therapeutics Inc

TRVI CIK 0001563880

Reporting Owner

Name	Relationship
David P Meeker CIK 0001385155	Director

David P Meeker at Trevi Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Trevi Therapeutics Inc

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Nonstatutory Stock Option (right to buy)F1 F2	$2.27	2022-06-23	A - Award/Grant	20,000 A	$0.00	2032-06-22	20,000 Common Stock	Direct

Footnotes (2)

F1: This option was granted on June 23, 2022. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer. Show more
F2: This amendment to the Form 4 originally filed for the reporting person on June 23, 2022 is being filed solely to attach the power of attorney exhibit that was inadvertently excluded from the original filing. Show more